Active Ingredient(s): Vosoritide
FDA Approved: * November 19, 2021
Pharm Company: * BIOMARIN PHARM
Category: Genetic Disorders

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".

Voxzogo Overview

Vosoritide, sold under the brand name Voxzogo, is a medication used for the treatment of achondroplasia.[1][2][3] The most common side effects include injection site reactions (such as swelling, redness, itching or pain), vomiting and decreased blood pressure.[1][2][3] Achondroplasia is a genetic condition that causes severely short stature and disproportionate growth.[2] The averag...

Read more Voxzogo Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Vosoritide

Recent Voxzogo Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

  • Injection: 0.4mg, 0.56mg, 1.2mg
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

Other drugs which contain Vosoritide or a similar ingredient: (1 result)